The treatment of periodontally compromised patients has been significantly altered by advances made with osseointegrated implants and growth factors. The tooth with moderate to advanced bone loss or a Class II furcation defect can be predictably replaced with a dental implant, and this may be the treatment of choice. Osseointegration has eliminated the need for many of the heroic tooth-borne restorations of the past. The application of the principles of periodontal prosthesis will help ensure the long-term success of dental implants. However, the availability of recombinant growth factors has enabled clinicians to successfully regenerate the damaged periodontium and allow such teeth to be a competent member of the patientís dentition. These biomaterials have expanded the scope of predictable therapy for both teeth and implants.
Myron Nevins, DDS, editor of The International Journal of Periodontics & Restorative Dentistry, is program director of the Department of Continuing Education and associate clinical professor of periodontology at Harvard School of Dental Medicine. He is director of the Institute of Advanced Dental Studies, former director and chairman of the American Board of Periodontology, and a past president of the American Academy of Periodontology. An adjunct professor in the Department of Periodontics at the University of North Carolina, Chapel Hill, Dr Nevins maintains a private practice limited to periodontics in Swampscott, Massachusetts.
Approximate Running Time: 60 minutes